148 related articles for article (PubMed ID: 24998949)
1. Antifungal activity of synthetic naphthoquinones against dermatophytes and opportunistic fungi: preliminary mechanism-of-action tests.
Ferreira Mdo P; Cardoso MF; da Silva Fde C; Ferreira VF; Lima ES; Souza JV
Ann Clin Microbiol Antimicrob; 2014 Jul; 13():26. PubMed ID: 24998949
[TBL] [Abstract][Full Text] [Related]
2. Terpinen-4-ol, tyrosol, and β-lapachone as potential antifungals against dimorphic fungi.
Brilhante RS; Caetano ÉP; Lima RA; Marques FJ; Castelo-Branco DS; Melo CV; Guedes GM; Oliveira JS; Camargo ZP; Moreira JL; Monteiro AJ; Bandeira TJ; Cordeiro RA; Rocha MF; Sidrim JJ
Braz J Microbiol; 2016; 47(4):917-924. PubMed ID: 27520529
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of novel nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
Tandon VK; Maurya HK; Mishra NN; Shukla PK
Eur J Med Chem; 2009 Aug; 44(8):3130-7. PubMed ID: 19349095
[TBL] [Abstract][Full Text] [Related]
4. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
Croxtall JD; Plosker GL
Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
[TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal activities of bis(alkylpyridinium)alkane compounds against pathogenic yeasts and molds.
Chen SC; Biswas C; Bartley R; Widmer F; Pantarat N; Obando D; Djordjevic JT; Ellis DH; Jolliffe KA; Sorrell TC
Antimicrob Agents Chemother; 2010 Aug; 54(8):3233-40. PubMed ID: 20530227
[TBL] [Abstract][Full Text] [Related]
6. Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections.
Sav H; Ozdemir HG; Altınbas R; Kiraz N; Ilkit M; Seyedmousavi S
Mycopathologia; 2016 Oct; 181(9-10):653-61. PubMed ID: 27193295
[TBL] [Abstract][Full Text] [Related]
7. In vitro antifungal activity of naphthoquinone derivatives.
Sasaki K; Abe H; Yoshizaki F
Biol Pharm Bull; 2002 May; 25(5):669-70. PubMed ID: 12033513
[TBL] [Abstract][Full Text] [Related]
8. 'On water' assisted synthesis and biological evaluation of nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
Tandon VK; Maurya HK; Verma MK; Kumar R; Shukla PK
Eur J Med Chem; 2010 Jun; 45(6):2418-26. PubMed ID: 20207052
[TBL] [Abstract][Full Text] [Related]
9. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.
Gehrt A; Peter J; Pizzo PA; Walsh TJ
J Clin Microbiol; 1995 May; 33(5):1302-7. PubMed ID: 7615745
[TBL] [Abstract][Full Text] [Related]
10. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Lass-Flörl C; Mayr A; Perkhofer S; Hinterberger G; Hausdorfer J; Speth C; Fille M
Antimicrob Agents Chemother; 2008 Oct; 52(10):3637-41. PubMed ID: 18694949
[TBL] [Abstract][Full Text] [Related]
11. Bioactivity-guided isolation and structural characterization of the antifungal compound, plumbagin, from Nepenthes gracilis.
Gwee PS; Khoo KS; Ong HC; Sit NW
Pharm Biol; 2014 Dec; 52(12):1526-31. PubMed ID: 25026359
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin.
Wildfeuer A; Seidl HP; Paule I; Haberreiter A
Mycoses; 1998; 41(7-8):309-19. PubMed ID: 9861837
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal activity of sertaconazole.
Drouhet E; Dupont B
Arzneimittelforschung; 1992 May; 42(5A):705-10. PubMed ID: 1627187
[TBL] [Abstract][Full Text] [Related]
15. Antifungal membranolytic activity of the tyrocidines against filamentous plant fungi.
Rautenbach M; Troskie AM; Vosloo JA; Dathe ME
Biochimie; 2016 Nov; 130():122-131. PubMed ID: 27328781
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of antifungal activity of naphthoquinone derivatives.
Errante G; La Motta G; Lagana C; Wittebolle V; Sarciron ME; Barret R
Eur J Med Chem; 2006 Jun; 41(6):773-8. PubMed ID: 16563569
[TBL] [Abstract][Full Text] [Related]
17. Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations.
Halliday CL; Chen SC; Kidd SE; van Hal S; Chapman B; Heath CH; Lee A; Kennedy KJ; Daveson K; Sorrell TC; Morrissey CO; Marriott DJ; Slavin MA
Int J Antimicrob Agents; 2016 Oct; 48(4):453-8. PubMed ID: 27562696
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
[TBL] [Abstract][Full Text] [Related]
19. Silver nanoparticles from Pilimelia columellifera subsp. pallida SL19 strain demonstrated antifungal activity against fungi causing superficial mycoses.
Wypij M; Czarnecka J; Dahm H; Rai M; Golinska P
J Basic Microbiol; 2017 Sep; 57(9):793-800. PubMed ID: 28670763
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the antimicrobial susceptibility of fungi responsible for onychomycosis in Spain.
Zalacain A; Obrador C; Martinez JP; Viñas M; Vinuesa T
Med Mycol; 2011 Jul; 49(5):495-9. PubMed ID: 21142899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
